论文部分内容阅读
支气管哮喘作为一种严重威胁人类健康的常见病,因其发病率呈上升趋势而受到世界的广泛关注,世界卫生组织及美国心肺血液研究所于1995年制定了(全球哮喘防治创议)(GINA)为哮喘的治疗提供了新的观念及诊疗规范,特别是哮喘的药物防治方面比以前有了较大的变更。为了了解永城地区哮喘的药物防治情况,我们针对每个患者设计了药物防治的问题调查表,对1999年1月至2001年3月首次来我院门诊就诊的,根据我国1993年标准(中华结核与呼吸杂志,1993哮喘增刊5～8)确诊的154例哮喘病人进行问卷调查,现将调查的结果及分析报告如下:
Bronchial asthma, a common disease that seriously threatens human health, has drawn worldwide attention due to its rising incidence. WHO and the American Heart Institute for Cardiopulmonary Research established the Global Initiative for Asthma Prevention (GINA) in 1995, Provides a new concept for the treatment of asthma and treatment norms, especially in the prevention and treatment of asthma have a larger change than before. In order to understand the prevention and treatment of asthma in Yongcheng area, we designed a questionnaire on the prevention and treatment of asthma in each patient. From January 1999 to March 2001, we came to our clinic for the first time. According to the standard of China 1993 Tuberculosis and Respiratory Diseases, 1993 Asthma Supplement 5 ~ 8) 154 cases of asthma confirmed by the questionnaire survey, the survey results and analysis are as follows: